-
iShares U.S. Healthcare Providers ETF (IHF $49.63)
- $49.63 P/E (TTM): 17.33X Cap: $801M
- View IHF Profile
- View Questions on IHF
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
iShares U.S. Healthcare Providers ETF (IHF $49.63)
- $49.63 P/E (TTM): 17.33X Cap: $801M
- View IHF Profile
- View Questions on IHF
-
Elevance Health Inc. (ELV $353.24)
- $353.24 P/E (TTM): 14.99X Cap: $79.54B
- View ELV Profile
- View Questions on ELV
Q: On Oct 22, concerning ELV's quarterly results, you said, "a key issue was the 'timing mismatch' between Medicaid reimbursement rates and the higher healthcare needs of members" - an issue linked to post-COVID resumption of full-service healthcare.
But isn't this a case of 'one-off' cyclicality in an industry which was assumed to be secular? In which case, doesn't ELV become mis-priced as reimbursements and higher needs fall back into balance?
Finally, to operationalize this strategy, would it be preferable to seek-out the most beaten-down health insurer (perhaps you have suggestions), or to pick something like IHF (ditto)?
But isn't this a case of 'one-off' cyclicality in an industry which was assumed to be secular? In which case, doesn't ELV become mis-priced as reimbursements and higher needs fall back into balance?
Finally, to operationalize this strategy, would it be preferable to seek-out the most beaten-down health insurer (perhaps you have suggestions), or to pick something like IHF (ditto)?
-
AbbVie Inc. (ABBV $230.50)
- $230.50 P/E (TTM): 110.29X Cap: $407.19B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $190.72)
- $190.72 P/E (TTM): 20.4X Cap: $459.31B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $833.49)
- $833.49 P/E (TTM): 54.48X Cap: $788.86B
- View LLY Profile
- View Questions on LLY
-
Thermo Fisher Scientific Inc (TMO $524.80)
- $524.80 P/E (TTM): 30.35X Cap: $198.17B
- View TMO Profile
- View Questions on TMO
-
UnitedHealth Group Incorporated (DE) (UNH $354.50)
- $354.50 P/E (TTM): 15.35X Cap: $321.06B
- View UNH Profile
- View Questions on UNH
-
Novo Nordisk A/S (NVO $56.93)
- $56.93 P/E (TTM): 16.0X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
iShares U.S. Medical Devices ETF (IHI $58.83)
- $58.83 P/E (TTM): 28.17X Cap: $4.07B
- View IHI Profile
- View Questions on IHI
-
iShares U.S. Healthcare Providers ETF (IHF $49.63)
- $49.63 P/E (TTM): 17.33X Cap: $801M
- View IHF Profile
- View Questions on IHF
Q: Hi,
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
Insiders
Share Information
SEC Filings
News and Media